Tag Archives: conflicts of interest

70% of psychiatrists in charge of adding new mental disorders to psych billing bible (DSM) have conflicts/ties to Pharma

Former editors of the Diagnostic and Statistical Manual of Mental Disorders (DSM) have publicly declared their concerns that the ongoing revision process of the influential publication has been cloaked in secrecy. Some critics of the DSM process express other concerns in addition to matters of transparency. It’s been pointed out that about 70% of current task force members have ties to the pharmaceutical industry, up about 14% from DSM-IV.

One of the Pharma funded psychiatrists that spearheaded national child drugging campaign

When asking the question, “Who is responsible?” there is at least one name that stands out. Dr. Joseph Biederman of Harvard University. Biederman is a very high-profile doctor that spear-headed the outbreak of children on psychiatric drugs. Biederman reportedly received $1.6 million from drug makers between 2000 and 2006. However, he failed to report most of this to his university, which may well have considered this to be a conflict of interest.

University of Miami under fire for hiring psychiatrist who took millions in Pharma funds and was “pharma pimping for Paxil”

Bernard Carroll, former head of psychiatry at Duke University and once Charles Nemeroff’s boss, said parts of Nemeroff’s work involved Paxil, a GlaxoSmithKline antidepressant. “Basically, he was doing basic science pimping for Paxil to produce talking points,” Carroll told The Herald in an e-mail Thursday. “All he ever produced was speculation but that was enough to satisfy Glaxo marketing. . . . I have been exposing his shenanigans for some years.”

Say what? Psychiatrist Charles Nemeroff who failed to report $1.2 mil in Pharma deals lands psych chairmanship at University

Last year Nemeroff, as chair of the Department of Psychiatry at Emory University, was the intense focus of an investigation by Sen. Charles Grassley, R-Iowa, who said he was concerned about the money the psychiatrist received from drug companies while conducting supposedly unbiased research for the National Institutes of Health on drugs made by the companies he was receiving money from.